4.2 Article

Navigating Breast Cancer: Axon Guidance Molecules as Breast Cancer Tumor Suppressors and Oncogenes

Journal

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Volume 16, Issue 3, Pages 257-270

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10911-011-9225-1

Keywords

Axon guidance molecules; Netrin; Semaphorin; Ephrin; Slit; Robo

Funding

  1. NIH [CA-128902]
  2. Congressionally Directed Medical Research Program [W81XWH-08-1-0380]
  3. Santa Cruz Cancer Benefit Group
  4. California Institute of Regenerative Medicine [TG2-01157]

Ask authors/readers for more resources

Slit, Netrin, Ephrin, and Semaphorin's roles in development have expanded greatly in the past decade from their original characterization as axon guidance molecules (AGMs) to include roles as regulators of tissue morphogenesis and development in diverse organs. In the mammary gland, AGMs are important for maintaining normal cell proliferation and adhesion during development. The frequent dysregulation of AGM expression during tumorigenesis and tumor progression suggests that AGMs also play a crucial role as tumor suppressors and oncogenes in breast cancer. Moreover, these findings suggest that AGMs may be excellent targets for new breast cancer prognostic tests and more effective therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available